https://openbell.ai/ 2026-11-02T20:45:59.806Z hourly 1.0 https://openbell.ai/support 2026-11-02T20:45:59.806Z monthly 0.7 https://openbell.ai/privacy 2026-11-02T20:45:59.806Z monthly 0.5 https://openbell.ai/terms 2026-11-02T20:45:59.806Z monthly 0.5 https://openbell.ai/feed.json 2026-11-02T20:45:59.806Z hourly 0.8 https://openbell.ai/news/EQIX:1793649714000 2026-11-02T20:01:54.000Z daily 0.9 https://cdn.brandfetch.io/EQIX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Equinix Reports Strong Q3 Results, Raises 2026 Guidance, and Announces $700 Million Stock Offering Equinix reported Q3 revenue of $2.57 billion, up 11% year over year, and net income of $489 million, up 31%. The company raised its 2026 revenue and AFFO-per-share guidance for the third consecutive quarter and projected 2026 cabinet deliveries nearly 40% above prior forecasts, with 3 GW of developable capacity. Equinix filed for a $700 million common stock offering and a shelf registration statement, and agreed to fund electrical grid infrastructure for a Georgia project. https://openbell.ai/news/PFE:1793649712000 2026-11-02T20:01:52.000Z daily 0.9 https://cdn.brandfetch.io/PFE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Pfizer Reports Q2 Revenue Growth and Raises Full-Year Outlook Pfizer reported second-quarter revenue growth of 18% year over year, excluding currency impacts. The company raised the midpoint of its full-year revenue forecast by $500 million. Pfizer is scheduled to release its complete quarterly financial results later this week. https://openbell.ai/news/INDV:1793646189000 2026-11-02T19:03:09.000Z daily 0.9 https://cdn.brandfetch.io/INDV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Supernus Pharmaceuticals Completes Merger With Indivior Pharmaceuticals Supernus Pharmaceuticals and Indivior Pharmaceuticals have completed their merger, combining their operations and resources to create a more diversified company focused on central nervous system biopharmaceuticals. The combined company plans to use its broader portfolio of marketed medicines and increased financial flexibility to strengthen its market position and support long-term growth. The article reports no financial terms or stock-price impact. https://openbell.ai/news/RAMP:1793646180000 2026-11-02T19:03:00.000Z daily 0.9 https://cdn.brandfetch.io/RAMP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Publicis Groupe Completes Acquisition of LiveRamp Publicis Groupe completed its acquisition of LiveRamp, previously valued at approximately $2.2 billion. The deal is intended to combine LiveRamp’s data collaboration and privacy expertise with Publicis’s broader capabilities to build a plug-and-play AI growth engine for clients. Publicis said LiveRamp will retain its existing identity, culture and neutrality; the transaction was financed with available cash and debt. https://openbell.ai/news/INDB:1793646167000 2026-11-02T19:02:47.000Z daily 0.9 https://cdn.brandfetch.io/INDB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Independent Bank Corp. Reports Third Quarter 2026 Results and Acquisition Completion Independent Bank Corp. reported adjusted third-quarter 2026 EPS of $0.80, down from $0.84 a year earlier. Net interest income increased, supported by growth in productive assets and expanded margins. The company completed its acquisition of HCB Financial Corp. during the quarter, and integration of the Highpoint Community Bank system is underway, with completion expected by November 9, 2026. https://openbell.ai/news/JOBY:1793646156000 2026-11-02T19:02:36.000Z daily 0.9 https://cdn.brandfetch.io/JOBY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Joby Aviation Reports Quarterly Results and Raises 2026 Revenue Outlook Joby Aviation reported quarterly revenue above analyst expectations but posted a wider-than-expected loss. It raised its 2026 revenue outlook to $115 million–$125 million. The company said five aircraft are flying and 12 are in production as it advances through the final stage of FAA certification, and launched a week-long Florida air-taxi flight series with the state’s transportation department, including a planned demonstration across Tampa Bay. https://openbell.ai/news/EW:1793646135000 2026-11-02T19:02:15.000Z daily 0.9 https://cdn.brandfetch.io/EW/w/400/h/400?c=1idopYfmtR7ZKg8QMud Edwards Lifesciences Announces Positive Results from CLASP II TR Trial for PASCAL System Edwards Lifesciences said its PASCAL system met the six-month primary endpoint in the CLASP II TR trial, showing superiority over medical therapy alone for tricuspid repair. Trial results showed a significant reduction in tricuspid regurgitation and sustained improvements in patient health status through one year. The findings were presented at the Transcatheter Cardiovascular Therapeutics scientific symposium. https://openbell.ai/news/ROKU:1793646129000 2026-11-02T19:02:09.000Z daily 0.9 https://cdn.brandfetch.io/ROKU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Fox Corporation Receives Shareholder and Foreign Regulatory Approvals for Roku Acquisition Fox Corporation said on November 2, 2026, that shareholders and foreign regulators have approved its proposed $22 billion acquisition of Roku. Fox is still seeking final antitrust clearance from the U.S. Department of Justice, amid scrutiny from some state attorneys general, and expects the deal to close in the first half of 2027. The approvals have narrowed the deal spread; the announcement did not report financial results or specific stock-price movements.